NUVB — Nuvation Bio Inc. price, chart and key statistics

Price data

Price

$4.77

YTD price return

-46.76%

YTD total return

-46.76%

Next earnings

Nov 2, 2026

Market cap

1.7B2020-12 1.7B2026-10 1.7B-4.0% over the window

Enterprise value

1.3B

Shares outstanding

351.1M2020-12 149M2026-06 351.1M+135.6% over the window

52W low

$3.45

52W high

$9.75

From 52W high

-51.08%

From 52W low

+38.26%

52W range

21%

Volume

Rel volume

1.24×

30D volume

5.5M

30D $ vol

29.8M

Fundamentals

Sales (ttm)

169.9M2023-12 02026-06 169.9M

Sales/share

$0.482023-12 $0.002026-06 $0.48

EPS (ttm)

-$0.582021-12 -$0.442026-06 -$0.58+31.5% over the window

FCF (ttm)

-181.4M2024-12 -130.4M2025-12 -181.4M+39.1% over the window

FCF/share

-$0.522024-12 -$0.392025-12 -$0.52+35.6% over the window

Book value/share

$0.722020-06 $0.692026-06 $0.72+4.7% over the window

Net margin

-88.19%2024-06 -35590.2%2026-06 -88.2%-99.8% over the window

ROE

-59.02%2021-12 -11.6%2026-06 -59.0%+407.0% over the window

ROA

-20.12%2021-12 -11.2%2026-06 -20.1%+79.8% over the window

Debt / equity

0.96×2025-06 0.132026-06 0.96+658.7% over the window

Current ratio

8.372020-12 33.692026-06 8.37-75.1% over the window

Growth (CAGR, ttm) · 10Y

Sales

+1085.56%2025-06-30 → 2026-06-3014.4M → 169.9M (+1083.6% total)n/an/an/a

Shares

+2.59%2025-06-30 → 2026-06-30342.3M → 351.1M (+2.6% total)+17.05%2023-06-30 → 2026-06-30218.9M → 351.1M (+60.4% total)+10.03%2021-06-30 → 2026-06-30217.8M → 351.1M (+61.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+1055.66%2025-06-30 → 2026-06-30$0.04 → $0.48 (+1053.7% total)n/an/an/a

Book value/share

-33.66%2025-06-30 → 2026-06-30$1.09 → $0.72 (-33.6% total)-36.71%2023-06-30 → 2026-06-30$2.85 → $0.72 (-74.7% total)-27.56%2021-06-30 → 2026-06-30$3.62 → $0.72 (-80.0% total)n/a

Price

+28.94%2025-10-20 → 2026-10-20$3.70 → $4.77 (+28.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+59.73%2023-10-20 → 2026-10-20$1.17 → $4.77 (+307.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-12.65%2021-10-20 → 2026-10-20$9.38 → $4.77 (-49.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+28.94%2025-10-20 → 2026-10-20$3.70 → $4.77 (+28.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+59.73%2023-10-20 → 2026-10-20$1.17 → $4.77 (+307.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-12.65%2021-10-20 → 2026-10-20$9.38 → $4.77 (-49.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-8.2×2021-12 -21.332026-10 -11.18-47.6% over the window

Fwd P/E

-318.0×

P/S (ttm)Market cap ÷ TTM revenue.

9.9×2024-09 356.492026-10 9.86-97.2% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

6.6×2020-12 8.112026-10 6.60-18.6% over the window

EV/Sales (ttm)

7.5×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-10.83%2024-12 -14.5%2025-12 -5.8%-59.7% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 351.1M ÷ 342.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-2.59%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.59%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($667.4M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-2.59%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2021-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.7B). Same caveat as the cash buyback yield.

0.00%2021-12 0.0%2026-06 0.0%

Vs own 10Y history

P/B

88th